IPO Boutique

Pfenex, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Pfenex, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Pfenex, Inc.PFNX -
NYSE
$8.00-$8.00 $6.00 $6.008.33 million7/24/2014
William Blair, JMP Securities
Co-Manager(s):
Mizuho Securities
Health Care
Filing(s):

Filed 2014-06-06
Terms Added 2014-07-07
Amended Terms 2014-07-17



Pfenex, Inc. Quote & Chart - Click for current quote - PFNX

About Pfenex, Inc. (adapted from Pfenex, Inc. prospectus):
They are a clinical-stage biotechnology company engaged in the development of difficult to manufacture and high-value proteins, initially focused on biosimilar therapeutics, or biosimilars.

This description is adapted from Pfenex, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Pfenex, Inc. "PFNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved